Latest News for: ocular

Edit

Notice of Proposed Sale of Securities (Form 144) (Ocular Therapeutix Inc)

Public Technologies 08 Oct 2026
). The text version of this document is not available ... Ocular Therapeutix Inc.
Edit

Oku Digital Health Launches From Topcon Healthcare to Accelerate Drug Development Using Ocular Data

Nasdaq Globe Newswire 06 Oct 2026
Oku announced its connected network of 10,000+ care locations, real-world ocular data & real-world evidence to help sponsors accelerate drug development ... .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Ocular Therapeutix Inc)

Public Technologies 06 Oct 2026
) FORM 4 ... See Instruction 1(b) ... OMB Number ... OCULAR THERAPEUTIX, INC [OCUL] 5 ... C/O OCULAR THERAPEUTIX, INC., 14 CROSBY DRIVE, 3RD FLOOR 3 ... C/O OCULAR THERAPEUTIX, INC ... (1) Represents shares of common stock of Ocular Therapeutix, Inc ... Ocular Therapeutix Inc.
Edit

Nanomerics Closes Series A Investment Round With a Strategic Investor and the Silverstein Dream Foundation

ACCESSWIRE 30 Sep 2026
The investment will allow Nanomerics to further develop its platform technologies, the Molecular Envelope Technology (MET) and METfect, and to advance its ocular pipeline.
Edit

TikToker Jordan Zwart raises awareness for ocular cancer after having an eye removed

News24 29 Sep 2026
‘I’m grateful to still be alive even though I’ve only got one eye’ .
Edit

Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know

The Call 23 Sep 2026
Among others, the following stocks were impacted.Specialty Pharmaceuticals company Ocular Therapeutix (NASDAQ ... Is now the time to buy ANI Pharmaceuticals? Access our full analysis report here, it’s free.Zooming In On Ocular Therapeutix (OCUL).
Edit

Ocular Motility Disturbance Market Set for Growth as Diagnostic Advances and Expanding Pipeline Reshape Treatment Landscape

GetNews 23 Sep 2026
Key Ocular Motility Disturbance companies such as Abbott Laboratories, Alcon Vision LLC, AbbVie Inc ... Curious to know what's driving the Ocular Motility Disturbance market through 2036? ... Key Takeaways from the Ocular Motility Disturbance Market Report.
Edit

Seeing beyond the surface: understanding the impact of ocular symptoms in myasthenia gravis (UCB SA)

Public Technologies 08 Jul 2026
Why ocular symptoms matter so much. Ocular symptoms can be visible and disruptive features of gMG. Patients may experience diplopia (double vision) and ptosis (eyelid drooping) because of weakness and fatigue in the ocular muscles.
Edit

Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases

PR Newswire 07 Jul 2026
Conventional eye drops clear from the ocular surface in minutes, driving dosing regimens of up to 20 times per day and contributing to treatment adherence rates as low as 20% in chronic-use populations ... Ophthalmology/ocular drug delivery Founders.
×